Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline Sequencing of DNA Damage Repair Genes in Two Hereditary Prostate Cancer Cohorts Reveals New Disease Risk-Associated Gene Variants. | Cancers (Basel) | 2024 | 39001544 | PubTator, text mining | PubMed |
| Endometrial serous carcinoma with a corded and hyalinized pattern: a clinicopathological and molecular analysis. | Pathologica | 2024 | 38979592 | PubTator, text mining | PubMed |
| Attenuated adenomatous polyposis with MSH6 variation: Two case reports. | Medicine (Baltimore) | 2024 | 38968511 | PubTator, text mining | PubMed |
| Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases. | Breast Cancer Res Treat | 2024 | 38874686 | PubTator, text mining | PubMed |
| Well-differentiated G1 and G2 pancreatic neuroendocrine tumors: a meta-analysis of published expanded DNA sequencing data. | Front Endocrinol (Lausanne) | 2024 | 38868744 | PubTator, text mining | PubMed |
| Carrier testing for partners of MUTYH variant carriers: UK Cancer Genetics Group recommendations. | J Med Genet | 2024 | 38816194 | PubTator, text mining | PubMed |
| Phenotype correlations with pathogenic DNA variants in the MUTYH gene. | medRxiv | 2024 | 38798681 | PubTator, text mining | PubMed |
| Exploring the Role of the MUTYH Gene in Breast, Ovarian and Endometrial Cancer. | Genes (Basel) | 2024 | 38790183 | PubTator, text mining | PubMed |
| Chemotherapy-free treatment targeting fusions and driver mutations in KRAS wild-type pancreatic ductal adenocarcinoma, a case series. | Ther Adv Med Oncol | 2024 | 38770091 | PubTator, text mining | PubMed |
| Murf1 alters myosin replacement rates in cultured myotubes in a myosin isoform-dependent manner. | In Vitro Cell Dev Biol Anim | 2024 | 38758432 | PubTator, text mining | PubMed |
Updated European guidelines for clinical management of familial adenomatous polyposis (FAP), MUTYH-associated polyposis (MAP), gastric adenocarcinoma, proximal polyposis of the stomach (GAPPS) and other rare adenomatous polyposis syndromes: a joint EHTG-ESCP revision. | Br J Surg | 2024 | 38722804 | PubTator, text mining | PubMed |
| A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America. | Fam Cancer | 2024 | 38687439 | PubTator, text mining | PubMed |
| Associations between pathological features and risk of metachronous colorectal cancer. | Int J Cancer | 2024 | 38676439 | PubTator, text mining | PubMed |
Curative resection via right hemicolectomy and regional lymph node dissection for colonic adenomatous polyposis of unknown etiology with adenocarcinomas localized in the right side of the colon: a case report. | Surg Case Rep | 2024 | 38647838 | PubTator, text mining | PubMed |
| Targeted genotyping for recurring variants in cancer susceptibility genes in non-Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years. | Cancer | 2024 | 38630906 | PubTator, text mining | PubMed |
| Genetic Complexity in Recurrent Basal Cell Carcinoma: A MUTYH Variant Case Report. | Cureus | 2024 | 38586659 | PubTator, text mining | PubMed |
| Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail. | NPJ Precis Oncol | 2024 | 38582894 | PubTator, text mining | PubMed |
| Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. | Cell | 2024 | 38552610 | PubTator, text mining | PubMed |
| Sebaceomas in a Muir-Torre-like Phenotype in a Patient with MUTYH-Associated Polyposis. | Dermatopathology (Basel) | 2024 | 38534264 | PubTator, text mining | PubMed |
| Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts. | J Cancer Res Clin Oncol | 2024 | 38526631 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=11